Baseline characteristics of patients.

<p>ARB, angiotensin II receptor blocker; IQR, interquartile range.</p><p>Baseline characteristics of patients.</p

Changes in the number of small intestinal mucosal breaks from baseline to posttreatment.

<p>Results were analyzed by the Wilcoxon signed-rank test.</p

Changes in the severity of small intestinal mucosal breaks from baseline to posttreatment.

<p>Results were analyzed by McNemar test.</p

Changes in the levels of hemoglobin and albumin after treatment with placebo or rebamipide.

<p>Results are expressed as medians and interquartile ranges (IQRs)</p><p>Changes in the levels of hemoglobin and albumin after treatment with placebo or rebamipide.</p

Capsule endoscopic images of small bowel mucosal breaks induced by low-dose enteric-coated aspirin.

<p>Typical photographs of mucosal breaks observed in this study are shown. A: a mucosal break (arrow). B: multiple mucosal breaks (arrows).</p

Trial flow diagram.

<p>Trial flow diagram.</p